EX-FILING FEES 9 rkda-exfiling_fees.htm EX-FILING FEES EX-FILING FEES

 

Exhibit 107

Calculation of Filing Fee Tables

Form S-4

(Form Type)

ARCADIA BIOSCIENCES, INC.

(Exact Name of Registrant as Specified in its Charter)

Table 1 - Newly Registered and Carry Forward Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Security
Type

Security
Class
Title

Fee
Calculation
or Carry
Forward
Rule

Amount
Registered

Proposed
Maximum
Offering
Price Per
Unit

Maximum
Aggregate
Offering
Price

Fee
Rate

Amount of
Registration
Fee

Carry
Forward

Form
Type

Carry
Forward
Initial
effective
date

Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward

 

 

Fees to Be

Paid

Equity

Common
Stock,
$0.001
par value

per share

Other

13,000,000(1)

(2)

$6,545,730(2)

$0.00015310

$1,002.16

Fees

Previously

Paid

Carry

Forward

Securities

Total Offering Amounts

$6,545,730 (2)

$1,002.16

Total Fees Previously Paid

Total Fee Offsets

Net Fee Due

$1,002.16

 

 

(1)

Relates to common stock, $0.001 par value per share, of Arcadia Biosciences, Inc., a Delaware corporation (the “Company”), issuable to the limited partners of Roosevelt Resources LP, a Texas limited partnership (the “Partnership”) in exchange for all of the limited partnership interests of the Partnership (the “Exchange”). The amount of the Company’s common stock to be registered includes the estimated maximum number of shares of common stock of the Company that are expected to be issued pursuant to the Exchange.

 

(2)

 

 

 

 

 

As there is no market for the limited partnership interests of the Partnership, the proposed maximum offering price per share was calculated using the book value of the limited partnership interests of the Partnership as of September 30, 2024, which amount equals $6,545,730, in accordance with Rule 457(f)(2) promulgated under the Securities Act of 1933, as amended (the “Securities Act”).

 

Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(f)(2) promulgated under the Securities Act, the proposed maximum aggregate offering price was calculated based upon the estimated book value of the limited partnership interests of the Partnership to be exchanged in the proposed transaction, as of immediately prior to the proposed transaction. The Partnership is a private company and no market exists for its securities.